Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Antiviral Res ; 221: 105793, 2024 01.
Article in English | MEDLINE | ID: mdl-38184111

ABSTRACT

CD163 expressed on cell surface of porcine alveolar macrophages (PAMs) serves as a cellular entry receptor for porcine reproductive and respiratory syndrome virus (PRRSV). The extracellular portion of CD163 contains nine scavenger receptor cysteine-rich (SRCR) and two proline-serine-threonine (PST) domains. Genomic editing of pigs to remove the entire CD163 or just the SRCR5 domain confers resistance to infection with both PRRSV-1 and PRRSV-2 viruses. By performing a mutational analysis of CD163, previous in vitro infection experiments showed resistance to PRRSV infection following deletion of exon 13 which encodes the first 12 amino acids of the 16 amino acid PSTII domain. These findings predicted that removal of exon 13 can be used as a strategy to produce gene-edited pigs fully resistant to PRRSV infection. In this study, to determine whether the deletion of exon 13 is sufficient to confer resistance of pigs to PRRSV infection, we produced pigs possessing a defined CD163 exon 13 deletion (ΔExon13 pigs) and evaluated their susceptibility to viral infection. Wild type (WT) and CD163 modified pigs, placed in the same room, were infected with PRRSV-2. The modified pigs remained PCR and serologically negative for PRRSV throughout the study; whereas the WT pigs supported PRRSV infection and showed PRRSV related pathology. Importantly, our data also suggested that removal of exon 13 did not affect the main physiological function associated with CD163 in vivo. These results demonstrate that a modification of CD163 through a precise deletion of exon 13 provides a strategy for protection against PRRSV infection.


Subject(s)
Porcine Reproductive and Respiratory Syndrome , Porcine respiratory and reproductive syndrome virus , Swine , Animals , Porcine respiratory and reproductive syndrome virus/genetics , Porcine Reproductive and Respiratory Syndrome/genetics , Macrophages, Alveolar , Gene Editing/methods , Exons
2.
Educ Inf Technol (Dordr) ; : 1-52, 2023 May 18.
Article in English | MEDLINE | ID: mdl-37361821

ABSTRACT

Being digitally competent is an imperative requirement for the 21st century university teacher, a fact recognized by both the literature and policymakers. Although this topic has been addressed in different reviews and critical studies recently, none of them have systematically and explicitly addressed the factors that explain, or are explained by, the digital competencies of university teachers. Examples of these factors include, among others, demographic, professional and psychological aspects of university teachers, as well as very specific digital competencies. The present study seeks to close this gap through a systematic mapping of the literature published until 2021 in journals indexed by Scopus and Web of Science (WOS). Based on the selection of 53 primary studies, we characterized the literature and summarized the main results reported so far. The analysis allowed us to conclude the following: 1) there is a growing number of contributions aimed at understanding the acquisition of digital competencies, especially from external factors; 2) European, and more specifically Spanish, university teachers from multiple disciplines are the most studied population; 3) most studies adopted quantitative approaches to explain but not prove causality; 4) there is a great heterogeneity of relationships and results that explain the digital competencies of university professors. The implications of these results are discussed with a view to identifying the gaps that provide scope for future research.

3.
Cells ; 13(1)2023 12 23.
Article in English | MEDLINE | ID: mdl-38201243

ABSTRACT

To better understand radiation-induced organ dysfunction at both high and low doses, it is critical to understand how endothelial cells (ECs) respond to radiation. The impact of irradiation (IR) on ECs varies depending on the dose administered. High doses can directly damage ECs, leading to EC impairment. In contrast, the effects of low doses on ECs are subtle but more complex. Low doses in this study refer to radiation exposure levels that are below those that cause immediate and necrotic damage. Mitochondria are the primary cellular components affected by IR, and this study explored their role in determining the effect of radiation on microvascular endothelial cells. Human dermal microvascular ECs (HMEC-1) were exposed to varying IR doses ranging from 0.1 Gy to 8 Gy (~0.4 Gy/min) in the AFRRI 60-Cobalt facility. Results indicated that high doses led to a dose-dependent reduction in cell survival, which can be attributed to factors such as DNA damage, oxidative stress, cell senescence, and mitochondrial dysfunction. However, low doses induced a small but significant increase in cell survival, and this was achieved without detectable DNA damage, oxidative stress, cell senescence, or mitochondrial dysfunction in HMEC-1. Moreover, the mitochondrial morphology was assessed, revealing that all doses increased the percentage of elongated mitochondria, with low doses (0.25 Gy and 0.5 Gy) having a greater effect than high doses. However, only high doses caused an increase in mitochondrial fragmentation/swelling. The study further revealed that low doses induced mitochondrial elongation, likely via an increase in mitochondrial fusion protein 1 (Mfn1), while high doses caused mitochondrial fragmentation via a decrease in optic atrophy protein 1 (Opa1). In conclusion, the study suggests, for the first time, that changes in mitochondrial morphology are likely involved in the mechanism for the radiation dose-dependent effect on the survival of microvascular endothelial cells. This research, by delineating the specific mechanisms through which radiation affects endothelial cells, offers invaluable insights into the potential impact of radiation exposure on cardiovascular health.


Subject(s)
Mitochondrial Diseases , Radiation Injuries , Humans , Endothelial Cells , Cell Survival , Mitochondria , Cellular Senescence , Mitochondrial Proteins
4.
Endocrinology ; 163(7)2022 07 01.
Article in English | MEDLINE | ID: mdl-35569056

ABSTRACT

Dysregulation of cholesterol homeostasis is associated with many diseases such as cardiovascular disease and cancer. Liver X receptors (LXRs) are major upstream regulators of cholesterol homeostasis and are activated by endogenous cholesterol metabolites such as 27-hydroxycholesterol (27HC). LXRs and various LXR ligands such as 27HC have been described to influence several extra-hepatic biological systems. However, disparate reports of LXR function have emerged, especially with respect to immunology and cancer biology. This would suggest that, similar to steroid nuclear receptors, the LXRs can be selectively modulated by different ligands. Here, we use RNA-sequencing of macrophages and single-cell RNA-sequencing of immune cells from metastasis-bearing murine lungs to provide evidence that LXR satisfies the 2 principles of selective nuclear receptor modulation: (1) different LXR ligands result in overlapping but distinct gene expression profiles within the same cell type, and (2) the same LXR ligands differentially regulate gene expression in a highly context-specific manner, depending on the cell or tissue type. The concept that the LXRs can be selectively modulated provides the foundation for developing precision pharmacology LXR ligands that are tailored to promote those activities that are desirable (proimmune), but at the same time minimizing harmful side effects (such as elevated triglyceride levels).


Subject(s)
Liver X Receptors , Mammary Neoplasms, Experimental , Myeloid Cells , Receptors, Steroid , Animals , Cholesterol/metabolism , Female , Ligands , Liver X Receptors/genetics , Liver X Receptors/metabolism , Macrophages/metabolism , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Mice , Myeloid Cells/metabolism , Myeloid Cells/pathology , Orphan Nuclear Receptors/genetics , Orphan Nuclear Receptors/metabolism , RNA/genetics , RNA/metabolism , Receptors, Steroid/metabolism
5.
PLoS One ; 16(9): e0257344, 2021.
Article in English | MEDLINE | ID: mdl-34506585

ABSTRACT

In this study, we report on a Systematic Mapping Study (SMS) on how the quality of the quantitative instruments used to measure digital competencies in higher education is assured. 73 primary studies were selected from the published literature in the last 10 years in order to 1) characterize the literature, 2) evaluate the reporting practice of quality assessments, and 3) analyze which variables explain such reporting practices. The results indicate that most of the studies focused on medium to large samples of European university students, who attended social science programs. Ad hoc, self-reported questionnaires measuring various digital competence areas were the most commonly used method for data collection. The studies were mostly published in low tier journals. 36% of the studies did not report any quality assessment, while less than 50% covered both groups of reliability and validity assessments at the same time. In general, the studies had a moderate to high depth of evidence on the assessments performed. We found that studies in which several areas of digital competence were measured were more likely to report quality assessments. In addition, we estimate that the probability of finding studies with acceptable or good reporting practices increases over time.


Subject(s)
Data Collection/standards , Education, Distance , Educational Technology , Curriculum , Data Interpretation, Statistical , Europe , Humans , Learning , Models, Statistical , Probability , Reproducibility of Results , Students , Surveys and Questionnaires , Systematic Reviews as Topic , Universities
6.
Int J Radiat Biol ; 93(9): 907-919, 2017 09.
Article in English | MEDLINE | ID: mdl-28749244

ABSTRACT

PURPOSE: Phenylbutyrate (PB), a histone deacetylase inhibitor (HDACi) has demonstrated radiation protection in both in vitro and in vivo models. Studies previously demonstrated that PB and other HDAC inhibitors could inhibit radiation lethality in vivo by subcutaneous (s.c) injection. The objective of this study was to test the ability of oral PB treatment to protect against or to mitigate acute gamma radiation-induced lethality in vivo. MATERIALS AND METHODS: Human osteoblasts cells were used to evaluate radiation survival when PB was delivered pre- or post-radiation. A 30-day radiation lethality study was used to assess the radioprotective (pre-radiation) and radiomitigative (post-radiation) capability of PB. Possible mechanisms evaluated were antioxidant activity effects, HDAC inhibition, DNA damage, and hematological recovery. RESULTS: Treatment of HOS cells with PB 50 µM either before or after radiation increased radiation resistance as assessed by clonogenic survival. Western blot studies showed that PB treatment acetylated histones in vivo and ameliorated the radiation-induced reduction in acetylated histone-4 (H4). Pre-radiation oral administration of PB (10 mg/kg) provided radioprotection against gamma radiation (7-11.5 Gy) with a dose reduction factor of 1.25 (p = 0.001). PB oral administration post-radiation provided moderate radiation mitigation against gamma radiation (7-11.5 Gy) and demonstrated a dose reduction factor of 1.18 (p = 0.05). PB pre-radiation and post-radiation treatment was associated with significant elevations in neutrophils and platelets and attenuation of DNA damage. CONCLUSIONS: These results indicate that oral PB has potential as a radiation protector and a radiation mitigator and that potential mechanisms of action include attenuation of DNA damage, antioxidant activity, and bone marrow protection.


Subject(s)
DNA Damage/drug effects , Gamma Rays , Osteoblasts/drug effects , Osteoblasts/radiation effects , Phenylbutyrates/pharmacology , Radiation Injuries/prevention & control , Reactive Oxygen Species/metabolism , Administration, Oral , Animals , Cell Line , Dose-Response Relationship, Drug , Feasibility Studies , Humans , Lethal Dose 50 , Male , Mice , Mice, Inbred DBA , Osteoblasts/cytology , Osteoblasts/physiology , Phenylbutyrates/adverse effects , Radiation Dosage , Radiation Injuries/diagnosis , Radiation-Protective Agents/adverse effects , Radiation-Protective Agents/pharmacology , Survival Rate , Treatment Outcome
7.
Toxicol Appl Pharmacol ; 331: 135-141, 2017 09 15.
Article in English | MEDLINE | ID: mdl-28602947

ABSTRACT

Depleted uranium (DU) is a radioactive heavy metal used primarily in military applications. Published data from our laboratory have demonstrated that DU exposure in vitro to immortalized human osteoblast cells (HOS) is both neoplastically transforming and genotoxic. In vivo studies have also demonstrated that DU is leukemogenic and genotoxic. DU possesses both a radiological (alpha particle) and chemical (metal) component but is generally considered a chemical biohazard. Studies have shown that alpha particle radiation does play a role in DU's toxic effects. Evidence has accumulated that non-irradiated cells in the vicinity of irradiated cells can have a response to ionization events. The purpose of this study was to determine if these "bystander effects" play a role in DU's toxic and neoplastic effects using HOS cells. We investigated the bystander responses between DU-exposed cells and non-exposed cells by co-culturing the two equal populations. Decreased cell survival and increased neoplastic transformation were observed in the non-DU exposed cells following 4 or 24h co-culture. In contrast Ni (II)- or Cr(VI)- exposed cells were unable to alter those biological effects in non-Ni(II) or non-Cr(VI) exposed co-cultured cells. Transfer experiments using medium from the DU-exposed and non-exposed co-cultured cells was able to cause adverse biological responses in cells; these results demonstrated that a factor (s) is secreted into the co-culture medium which is involved in this DU-associated bystander effect. This novel effect of DU exposure could have implications for radiation risk and for health risk assessment associated with DU exposure.


Subject(s)
Bystander Effect/drug effects , Bystander Effect/radiation effects , Osteoblasts/drug effects , Osteoblasts/radiation effects , Radiation Exposure/adverse effects , Uranium/toxicity , Bystander Effect/physiology , Cell Survival/drug effects , Cell Survival/physiology , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/radiation effects , Coculture Techniques/methods , Humans , Osteoblasts/physiology , Uranyl Nitrate/toxicity
8.
Radiat Environ Biophys ; 50(4): 585-96, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21892632

ABSTRACT

The histone deacetylase inhibitor (HDAC), phenylbutyrate (PB), is a novel anti-tumor agent. Studies have demonstrated that HDAC inhibitors can suppress cutaneous radiation syndrome and stimulate hematopoiesis. The objective of this study was to test the ability of PB treatment to protect against acute gamma-radiation-induced lethality in the DBA/2 mouse model. A 30-day radiation lethality study was used to assess radioprotective capability of PB. Mechanisms were evaluated using western blots, flow cytometry, and the single-cell gel electrophoresis assay. Western blot studies showed that PB treatment acetylated histones in vivo. For radiation protection studies, prophylactic administration of PB (24 h preradiation; 1-50 mg/kg) provided radioprotection against gamma radiation (8-9.5 Gy) and PB demonstrated a DRF of 1.31 (P = 0.001; 95% confidence interval: 1.27, 1.36). When PB (10 mg/kg) was administered post-radiation (4 h), it also provided significant radioprotection at 8.0 Gy radiation (P = 0.022). PB treatment before radiation was associated with significant elevations in neutrophils and platelets following radiation. Results from single-cell gel electrophoresis of peripheral blood leukocytes demonstrated that PB treatment before radiation can attenuate DNA damage and inhibit radiation-induced apoptosis. These results indicate that an HDAC inhibitor like PB has potential as a radiation protector and that mechanisms of action include attenuation of DNA damage and inhibition of apoptosis.


Subject(s)
Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Phenylbutyrates/pharmacology , Radiation-Protective Agents/pharmacology , Animals , Blood Platelets/drug effects , Blood Platelets/radiation effects , DNA Damage , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/radiation effects , Hematopoiesis/drug effects , Hematopoiesis/radiation effects , Histone Deacetylase Inhibitors/toxicity , Male , Mice , Phenylbutyrates/toxicity , Radiation-Protective Agents/toxicity , Survival Rate , Toxicity Tests, Acute
9.
Health Phys ; 99(3): 371-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20699700

ABSTRACT

Depleted uranium (DU) is an alpha particle emitter and radioactive heavy metal used in military applications. Due to internalization of DU during military operations and the ensuing chronic internal exposure to DU, there are concerns regarding its potential health effects. Preconceptional paternal irradiation has been implicated as a causal factor in childhood cancer and it has been suggested that this paternal exposure to radiation may play a role in the occurrence of leukemia and other cancers to offspring. Similarly, in vivo heavy metal studies have demonstrated that carcinogenic effects can occur in unexposed offspring. Using a transgenic mouse system employing a lambda shuttle vector allowing mutations (in the lacI gene) to be analyzed in vitro, we have investigated the possibility that chronic preconceptional paternal DU exposure can lead to transgenerational transmission of genomic instability. The mutation frequencies in vector recovered from the bone marrow cells of the F1 offspring of male parents exposed to low, medium, and high doses of internalized DU for 7 mo were evaluated and compared to control, tantalum, nickel, and gamma radiation F1 samples. Results demonstrate that as paternal DU-dose increased there was a trend towards higher mutation frequency in vector recovered from the DNA obtained from bone marrow of F1 progeny; medium and high dose DU exposure to P1 fathers resulted in a significant increase in mutation frequency in F1 offspring (3.57 +or - 0.37 and 4.81 + or - 0.43 x 10; p < 0.001) in comparison to control (2.28 + or - 0.31 x 10). The mutation frequencies from F1 offspring of low dose DU, Ta- or Ni-implanted fathers (2. 71 + or - 0.35, 2.38 + or - 0.35, and 2.93 + or - 0.39 x 10, respectively) were not significantly different than control levels (2.28 + or - 0.31 x 10). Offspring from Co (4 Gy) irradiated fathers did demonstrate an increased lacI mutation frequency (4.69 + or - 0.48 x 10) as had been shown previously. To evaluate the role of radiation involved in the observed DU effects, males were exposed to equal concentrations (50 mg U L) of either enriched uranium or DU in their drinking water for 2 mo prior to breeding. A comparison of these offspring indicated that there was a specific-activity dependent increase in offspring bone marrow mutation frequency. Taken together these uranyl nitrate data support earlier results in other model systems showing that radiation can play a role in DU-induced biological effects in vitro. However, since the lacI mutation model measures point mutations and cannot measure large deletions that are characteristic of radiation damage, the role of DU chemical effects in the observed offspring mutation frequency increase may also be significant. Regardless of the question of DU-radiation vs. DU-chemical effects, the data indicate that there exists a route for transgenerational transmission of factor(s) leading to genomic instability in F1 progeny from DU-exposed fathers.


Subject(s)
Genomic Instability/genetics , Genomic Instability/radiation effects , Neoplasms, Radiation-Induced/chemically induced , Paternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/genetics , Uranium/toxicity , Alpha Particles , Animals , Bone Marrow/metabolism , Bone Marrow/radiation effects , DNA Damage/genetics , Dose-Response Relationship, Radiation , Female , Lac Repressors/genetics , Leukemia/chemically induced , Leukemia/genetics , Leukemia/metabolism , Male , Mice , Mice, Transgenic , Mutation , Neoplasms, Radiation-Induced/genetics , Neoplasms, Radiation-Induced/metabolism , Pregnancy , Prenatal Exposure Delayed Effects/metabolism , Uranium/metabolism
10.
Biochimie ; 91(10): 1328-30, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19324073

ABSTRACT

OBJECTIVES: The radioactive heavy metal depleted uranium (DU) is used in kinetic-energy penetrators in military applications. The objective of this study was to determine involvement of DNA methylation in DU-induced leukemia. METHODS: Methylation was measured by direct analysis of 5-methylcytosine content of spleen DNA in DU leukemic mice. RESULTS: Spleen hypomethylation occurred during DU-induced leukemogenesis (chronic internal DU exposure). Aberrant gene transcription was also detected. CONCLUSIONS: Epigenetic mechanisms are implicated in DU-induced leukemia. These data are evidence of aberrant DNA hypomethylation being associated with DU leukemogenesis.


Subject(s)
DNA Methylation/drug effects , Leukemia/chemically induced , Leukemia/genetics , Uranium/toxicity , Animals , Blotting, Northern , Male , Mice
11.
Med. fam. (Caracas) ; 6(1): 36-38, ene.-dic. 1998.
Article in Spanish | LILACS | ID: lil-391296

ABSTRACT

Con el propósito de evaluar el efecto terapéutico del Albendazol durante tres días de tratamiento, en la giardiasis en niños, se realizó un estudio clínico que incluyó un universo de 54 pacientes en edad preescolar, que no habían recibido tratamiento antihelmíntico en los dos meses previos y en quienes se demostró la presencia del protozoario mediante estudio coproparasitólogo seriado. Se administró una dosis de 400 mg de albendazol OD por vía oral durante tres días consecutivos. Se realizó control parasitólogo a los siete días de la última dósis, encontrándose una erradicación parasitaria del 93 por ciento. Los resultados obtenidos mostraron que el Albendazol administrado a la dosis ya descrita, provee una cura parasitóloga en la giardiais, sin embargo queda abierta la posibilidad sobre esta alternativa terapéutica.


Subject(s)
Humans , Male , Female , Child , Albendazole , Child , Giardiasis , Anthelmintics , Anthelmintics/therapeutic use , Parasitology
12.
Arch. latinoam. nutr ; 48(3): 197-200, Sept. 1998. ilus, tab
Article in Spanish | LILACS | ID: lil-226063

ABSTRACT

En algunos individuos con limitaciones funcionales y/o en ciertas áreas de trabajo, la determinación precisa de talla y peso presenta dificultades. Existe sin embargo, la alternativa de estimar estas variables a través de mediciones de segmentos corporales como la altura de la rodilla (AR) y la circunferencia media del brazo (CMB). En una muestra de 113 niños venezolanos de ambos sexos, clínicamente normales, de edades entre 9 y 14 años, se evaluaron las ecuaciones sugeridas por los Laboratorios Ross para estas estimaciones. Se evidenció la necesidad de ajustar estas ecuaciones a la población en estudio mediante análisis de regresión múltiple. Esto permitió generar tablas de talla y peso estimados a partir de AR y CMB para niños venezolanos.


Subject(s)
Humans , Child , Adolescent , Male , Female , Arm , Body Height , Body Weight , Knee , Arm/anatomy & histology , Venezuela
13.
Bol. Hosp. Niños J. M. de los Ríos ; 30(1): 31-5, ene.-abr. 1994. ilus
Article in Spanish | LILACS | ID: lil-141357

ABSTRACT

A propósito de un caso se destacan aquellos aspectos útiles en el diagnóstico, tratamiento y pronóstico de la toxoplasmosis congénita; ésta última problema de relevancia en el Edo. Nueva Esparta. Se insiste en las medidas preventivas y recomendaciones para enfrentar este problema


Subject(s)
Infant , Humans , Male , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis, Congenital/pathology , Toxoplasmosis/complications , Toxoplasmosis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...